The term "rhinovirus" (1-3) is now used to designate a group of immunologically distinct respiratory viruses, possessing many properties of enteroviruses but differing by lability in acid media (4) (5) (6) and almost exclusive multiplication in the nasopharynx. The first agents isolated that fit this description were the JH and 2060 strains of ECHO 28 isolated by Price (7) and Pelon, Mogabgab, Phillips, and Pierce (8) in 1956 and classified by Pelon (9) . Modifications in tissue culture technique for isolating these and similar agents, i.e., incubation on a rotating drum and reduction in pH to 7.0 to 7.3, were introduced by Pelon and Mogabgab (10) and extended by Tyrrell and associates (4) and Tyrrell and Parsons (5) to include an incubation temperature of 330 C and use of human tissues. Subsequently, many rhinoviruses, reported under a variety of names, have been isolated in association with mild respiratory illnesses (11) (12) (13) (14) (15) (16) . Some of the strains grow only in tissues of human origin (H strains) and some as well in monkey kidney tissue culture (M strains) (3, 5) . It has been estimated that rhinoviruses account for 35 to 40%o of the common colds in adults (17) .
Tyrrell, Bynoe, and co-workers (4, (18) (19) (20) and Jackson, Dowling, and Mogabgab (21) , who have administered rhinoviruses to volunteers, have demonstrated that the viruses can infect and produce common colds and that protection is associated with the presence of specific neutralizing antibody in the serum. After the isolation of other strains of rhinovirus, NIH 353, 1734, and 11757, by Johnson and associates (16) , our studies were undertaken in volunteers to determine the viruses' properties as infectious agents of man. The results were in agreement with the findings of previous observers but in addition revealed the existence of a substantial resistance to homologous rechallenge that is distinct from the more limited protective effect of naturally acquired antibody.
Materials and Methods
Volunteers and clinical procedures. Subjects were fifty-seven adult male volunteers from several federal correctional institutions who had no medical contraindications to the inoculations. Twenty-eight were inoculated at the Clinical Center, National Institutes of Health, and the remainder were inoculated at the Federal Prison Camp, Greenville, South Carolina. The inoculum used, the dose, the location, the date, and the identifying numbers of participants are shown in Table I .
At the Clinical Center, men were isolated, three per room, for 4 days before and for 10 days after inoculation. The volunteers were examined daily before and after inoculation by physicians who did not know which of several viruses (including agents other than rhinoviruses) had been given.
At Greenville, S. C., the men were assigned to two large, adjoining rooms without isolation; they continued their usual work assignments around the camp. Physicians who made daily examinations for 5 days were aware of which agent had been administered. The Greenville, S. C., studies were made in August and September, 1962 . Respiratory illness was infrequent in the camp in the early part of the period, but a mild outbreak of common cold occurred in late September. Some extraneous rhinoviruses were isolated at this time and on two other occasions. These are described under Results.
Inocula. The three virus strains used, NIH 353, NIH 1734, and NIH 11757, were isolated from throat swab specimens from two Marine recruits and a 2-year-old female (16) . Johnson and Rosen have described the characteristics of these three strains, which grow only in tissue of human origin (22) . All were isolated in a 56 human embryonic fibroblast cell culture (WI-26) (23) , and the harvest of a second WI-26 passage of each strain was pooled for a volunteer inoculum. Each volunteer inoculum was centrifuged for 20 minutes at 2,000 rpm, filtered through an 800-mA gradocol membrane, and stored in 2-ml amounts in heat-sealed ampules at -600 C. Inocula were safety tested in a manner previously described (24) . Volunteers were given 1 ml of virus suspension intranasally with a coarse hand spray and another 1 ml by intranasal instillation with a pipette.
Nasal secretions. The daily amount of nasal discharge in grams was determined by collecting from each subject used paper handkerchiefs in plastic bags and weighing these tissues. From this value was subtracted the weight of a like number of unused tissues. To correct for any pre-existing rhinorrhea, the weight of secretion in the 48 hours before inoculation was subtracted from that of the 48 hours after inoculation.
Collection of specimens. Swabs from subjects were agitated in vials with 2 ml of veal infusion broth containing 0.5%o bovine albumin and antibiotics. The swabs were then discarded. Nasopharyngeal washings were performed by instilling 5 ml of the above medium into each nostril with the subject's head tilted back and then, with his head tilted forward, collecting the fluid in disposable paper cups. After being mixed, the wash specimen was dispensed in vials. Pharyngeal and nasal swabbings were always performed before nasopharyngeal washes. The isolation results reported are derived from the nasopharyngeal wash specimen alone unless otherwise specified. Essentially identical isolation results were obtained whether specimens were cultured for virus when fresh or when recultured after storage at -200 C for 1 to 10 weeks. At Greenville, S. C., specimens were stored at -40 C for several days before shipment to the Clinical Center.
Stool specimens were collected and stored at -200 C. no illness (but some nasal discharge may be present); + = rhinitis with nasal congestion and discharge; ++ = nasal congestion, discharge, and systemic reaction; ± ++ = nasal and systemic findings and fever (. 37.5°C, oral). This classification is used in subsequent parts of the report. Nasal secretions. The case described in Figure 1 is representative of the concurrence of illness and the period of increased nasal secretion in men who became ill among the 27 on whom such data were available. Analyses of data on nasal secretion have been limited to the first 48 hours after inoculation, when the quantity of nasal secretion was maximal. The average weight of excess of secretions (see Methods) for the 27 men in this 2-day period was 8.5 g, with a range from 0.0 to 85.5 g. There was a close correlation between the amount of secretion and the severity of illness [Kendall's tau = +.543, p <.01 (26) ]. The quantity of nasal secretion did not correlate with the duration of virus shedding nor with the titer of postchallenge antibody. The number of tissues used correlated with the weight of collected secretions (Kendall's tau = +.688, p <.01).
Changes in leukocyte counts and sedimentation rates. Total leukocyte and differential counts were available on 15 subjects (Volunteers 1 to 9, 18 to 22, and 24) in the period before challenge and on days 1, 2, 3, and 7 to 10 after challenge. Thirteen of these men developed illness. The average counts for leukocytes, neutrophiles, and lymphocytes shown in Figure 2 revealed a moderate but significant increase in total leukocytes because of an increase in the absolute number of circulating neutrophiles during the acute illness. Analysis of the individual series of counts by the paired sample t test (27) (Figure 2) showed that the changes in average counts were due to uniform changes in counts from each volunteer. Of interest was the slight decrease in lymphocytes during the acute illness.
Erythrocyte sedimentation rates (ESR) were determined at the same times as the leukocyte counts. Five of the men (Volunteers 2, 3, 4, 7, and 9) developed ESR elevations in the range of 27 to 50 (Westergren) by 7 to 10 days after challenge. None of the other volunteers tested had ESR elevations greater than 16 at this time.
Comparison of virus yield according to source of specimen. The proportion of specimens yield- ing virus was determined for the nasopharyngeal wash, nasal swab, and pharyngeal swab specimens from 13 antibody-free (< 1: 2) volunteers during the 7-day interval following challenge. As shown in Figure 3 With consideration for the minimal time needed to develop antibody response, the volunteers with naturally acquired antibody must have had initial contact with 1734 virus a minimum of 6 weeks before challenge. The distribution of antibody titers in the volunteers chosen for study is a fair representation of the antibody levels found in the correctional institution population as a whole, with 20 to 40% being free of detectable antibody. All of the sera taken from volunteers immediately before challenge were tested in a single neutralization test to achieve a valid ranking according to prechallenge antibody titer. Paired sera were tested for rise in titer in one or more separate neutralization tests. Volunteers who had no detectable antibody were included in each study, and results from their challenge are tabulated in Table  III. According to the data in Tables III and V Extraneous viruses were isolated from 8 volunteers during the course of these studies (Table  VI) . Each of these volunteers had been inoculated with NIH 1734, but nasopharyngeal wash specimens contained a virus that was not neutralized by guinea pig serum specific for NIH 1734. These extraneous virus strains all produced en- (21, 28) . Illness usually began within 24 hours of inoculation, and there was considerable uniformity of the syndrome regardless of the virus strain used and the antibody status of the inoculated volunteer. The illness resembled what has classically been described as "common cold," with nasal discharge and obstruction, rapid recovery, and few sequels. A slight but significant leukocytosis due to neutrophiles occurred on the first and second days following challenge with a simultaneous slight decrease in lymphocytes. Similar changes in neutrophile counts have also been noted in this laboratory in studies with Coxsackie A-21 (29) . The independent finding of a positive correlation between increasing nasal secretions and severity of illness offers confirmation of the accuracy of the clinical observations on the volunteers.
Establishing that the illnesses were related to the virus strain given was important, and such was done with the inoculum most extensively employed, NIH 1734; there was shown to be a significant reduction in frequency and severity of illness as the titer of naturally acquired prechallenge antibody increased (p =..03). Sixteen additional volunteers with prechallenge antibody titers of < 1: 2 or 1: 2 have been challenged with NIH 1734 in a dose of 102-8 TCID50 as part of a separate study (30). They all developed colds with an average illness identical to that of the 13 antibody-free volunteers included in the present report. This enhances the confidence in the association of decreasing illness with increasing prechallenge antibody. Evidence that neither the inoculation procedure itself, nor some unrecognized agent in the NIH 1734 inoculum produced illness has been obtained by giving 6 volunteers this inoculum, which had been inactivated with specific hyperimmune guinea pig serum prepared against a strain grown in different cells. There was no illness or virus shedding in this group (30).
The superiority of the nasopharyngeal washing method over nose and pharyngeal swabs for recovery of virus in the present study confirms a similar finding with the HGP agent by Bynoe and associates (19) . With specimens obtained by this method, virus was recovered from 47 of 57 volunteers. Frequent occurrence of virus shedding more than 10 days after challenge and at least 5 days after acute illness is over has not been generally appreciated, but the very rare recovery of these strains from stool or rectal swab specimens is in keeping with the experience of others (1) .
Neutralizing antibody titers were determined against small doses of virus, which gave a sensitive, reproducible test. Fourfold or greater rises in titer were detected in sera from 47 of 56 (84%) volunteers 3 weeks after challenge. No increases in titer occurred in sera from 9 volunteers between the third and fourth weeks, and only 3 of 8 demonstrated a further . fourfold rise at 2 months despite intervening homologous rechallenge. Jackson and co-workers (31) have presented data to the effect that following challenge with an infectious nasal secretion containing an unknown "common cold" virus, the capacity of convalescent serum to inactivate the same or antigenically similar infectious nasal secretions continues to increase in titer for 1 year. This finding, despite differences in methodology, does not appear to be in keeping with our studies, The 8 volunteers who received homologous rechallenge at 1 month had relatively low titers of antibody (mean titer, 1: 10) and yet exhibited substantial resistance to the second challenge. They developed no illness following reinoculation and almost no virus shedding (57% of specimens positive for virus in the first week). In contrast, illnesses occurred in 13 of 25 volunteers with naturally acquired antibody (mean titer, 1: 86), and there was a 45% incidence of specimens positive for virus the first week following inoculation. These results suggest a mechanism of resistance in the rechallenge group other than that afforded by circulating antibody as usually measured. Of possible significance in explaining this phenomenon is the 1-month time interval between the challenges, as opposed to an estimated interval of at least 6 weeks and probably longer between natural infection and inoculation of the naturally acquired antibody group, i.e., some relatively short-lived mechanism of resistance.
A similar phenomenon, undoubtedly involving more than one virus strain, has been described by Dochez, Shibley, and Mills (32) in chimpanzees. They found that these animals rarely developed colds spontaneously or after inoculations within 3 months of a previous infection. Sabin (33, 34) has described a possibly related situation in the resistance to reinfection of the gastrointestinal tract, lasting more than 1 year after oral attenuated poliovirus vaccine. This resistance appears to be independent of serum antibody and is not conferred by 2 doses of parenteral Salk vaccine.
A possible mechanism of local resistance to reinfection suggested by Stuart-Harris and Francis (35) may have relevance to the present results. They observed in ferrets, following challenge with influenza, a change from the normal columnar epithelium of the respiratory tract to a transitional reparative form resistant even to chemical injury. The resistance lasted 3 to 4 weeks. Another mechanism of local resistance to be considered is an effect of interferon. Resistance to rechallenge with rhinoviruses was present 1 month after first challenge and for an average period of 13 days after cessation of virus shedding. This would require the local persistence of interferon in the absence of evident viral mniultiplication for a period longer than has been experimentally recorded (36) . On this basis it seems unlikely that interferon is the responsible factor in resistance to rechallenge.
The appearance of antibody in the nasal secretions in response to infection is thought to be important in reduction of virus spreading and prevention of illness (20, 37) . However, iil volunteers with naturally acquired antibody, there was relatively poor protection against illness and frequently prolonged virus shedding. This suggests that specific antibody in the nasal secretions does not account for the potent protection observed on rechallenge. Thus, resistance to reinfection with rhinoviruses not dependent on circulating neutralizing antibody as usually measured has not been satisfactorily explained and remains an important subject for study.
One of the difficulties of performing virological studies in human volunteers, the appearance of extraneous viruses, was amply demonstrated in these studies. It was possible, however, to prevent these events from significant interference with interpretation of the results. Dual infection with two rhinoviruses was detected in at least 6 volunteers (21, 36, 46, 49, 51, and 55, Table VI ). Assuming that the volunteers were not exposed to the two infecting rhinoviruses simultaneously, then there was limited resistance to superinfection early in the course, as compared to the potent protection observed on homologous rechallenge at 1 month. If a nonspecific mechanism of resistance is involved, then it is apparently not induced in the first few hours or days of the initial infection.
The rare occurrence of heterologous antibody responses in the present volunteers is evidence for the antigenic distinctiveness of the strains studied, as had been previously demonstrated in animals by Johnson and Rosen (22) . With the apparent multiplicity of serologically distinct strains of rhinovirus (6) and the relatively poor protection afforded by specific antibody in these studies, control of the common cold by means of parenteral vaccines will apparently be a formidable task.
Summary
Inoculation of adult male volunteers with three strains of rhinovirus, NIH353, 1734, and 11757, was followed by a high frequency of common colds. The illnesses usually began the day after inoculation and lasted 2 to 3 days. Rhinorrhea and a slight but significant neutrophilic leukocytosis with a drop in lymphocytes accompanied the acute illness.
Shedding of virus was detected in nasopharyngeal wash specimens from 47 to 57 volunteers, and persisted for a period of from 1 to 2 weeks in most cases. Fourfold or greater rises in neutralizing antibody titer were detected in 84% of the volunteers by using low doses of virus in a sensitive, reproducible test.
Evidence for the rhinovirus etiology of the observed illnesses was the significant correlation of decreasing frequency and severity of illness with increasing titers of naturally acquired, prechallenge neutralizing antibody versus NIH 1734. Antibody protection was limited, however, as demonstrated by several illnesses and frequent virus shedding in subjects with antibody before challenge. In contrast, volunteers homologously rechallenged with the three agents at 1 month, when induced antibody titers were relatively low, exhibited complete resistance to illness and almost complete absence of virus shedding. Evidence suggests that this resistance, apparently independent of serum antibody, is of brief duration; its mechanism remains obscure.
